Experimental study of anti-inflammatory activity of the new combined with drug urolytolytic action.
DOI:
https://doi.org/10.26641/2307-0404.2015.2.45643Keywords:
urolithiasis, inflammation, biologically active substances, flavonoids, anti-inflammatory activityAbstract
Herbal medicines provide their versatile complex influence on the course of the pathological process in the kidneys due to biologically active compounds. Specifically, they cause the direct impact on the concrements formation. The search of drugs which would contain high biological compounds of plant origin is an actual issue of modern pharmacology. The aim of investigation was to study the anti-inflammatory activity of the new combined drug of urolytolytic action, which includes the total plant extract and succinate buffer complex. Materials and methods: aseptic exudative inflammation was caused by subplantar introduction of 0,1 ml of 1% solution of λ-karahenin in the right hind paw of rats, the investigated drug was administered at doses 1, 2 and 4 ml/kg. The influence of the studied drug was evaluated in terms of swelling limbs volume. It is shown that the severity of antiexudative action of flarosukcinehad dose-dependent nature, increasing from dose of 1,0 ml/kg to 2,0 ml/kg (by 5,5%). Further dose increase to 4,0 ml/kg, was not defined by significant increase of activity. Anti-inflammatory activity of the drug ranged from 25 to 33%, which can be regarded as quite distinct, since in pharmacological study of anti-inflammatory drugs pharmacological activity level of at least 20%is significant.
References
Toropova AA, Batotcirenova ET, Olejnikov DN. [Antioxidant activity of dry groundwater bodies extract Astragalus membranaceus and its fractions]. Siberian Medical Journal. 2012;114(7):107–9. Russian. 2. Stefanov AV. [Preclinical drugs studies: method. rivers.]. 2002;528. Russian. 3. Makarova MN. [Bioavailability and metabolism of flavonoids]. Experimental and Clinical Pharmacology. 2011;74(6):33–40. Russian. 4. Popov AM, Krivoshapko ON, Artyukova AA. [Mecha¬nisms of protective pharmacological activity of flavonoids]. Biopharmaceutical magazine. 2012;4(4):27–41. Russian. 5. Rebrov OU. [Statistical analysis of medical data. Application software package Statistica (4th ed.)]. 2006;312. Russian. 6. Rybolovlev YR, Rybolovlev RS. [Dosage of sub¬stances for mammalian by constants of biological acti¬vity]. 1979;6:1513–16. Russian. 7. Tareeva IE. [Kidney Disease: A Guide for doctors]. 2000;413–21. Russian. 8. Chekman ІS. [Fіtotherapy: experimental-clinic aspect]. Eksperimentalna i klіnіchna medicine. 2007;1:11–14. Ukrainian. 9. European convention for the protection of vertebrate animals used for experimental and other scien¬tific purpose. Council of Europe, Strasbourg. 1986;52. 10. Cazarolli LH, Zanatta L, Alberton EH. Fla¬vo¬noids: prospective drug candidates. Mini Reviews in Medicinal Chemistry. 2008;8(13):1429–40.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Medical Perspectives
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
